PPHN: Is sildenafil the new nitric? A review of the literature

Advances in Neonatal Care

Volumn 10, Issue 2, 2010, Pages 69-74

  Spillers, Jana ^a,b,c  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b BAYLOR UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Fetal circulation; Inhaled nitric oxide; INO; Neonatal pulmonary hypertension; Neonate; Persistent fetal circulation syndrome; Persistent pulmonary hypertension; PPHN; Sildenafil

Indexed keywords

EID: 77952257220     PISSN: 15360903     EISSN: None     Source Type: Journal    
DOI: 10.1097/anc.0b013e3181d5c501     Document Type: Article

References (17)

1. Baquero H, Soliz A, Neira F, Venega M, Sola A. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics. 2006;117:1077-1083.
2. Shah P, Ohlsson A. Sildenafil for pulmonary hypertension in neonates (review). Cochrane Database Syst Rev. 2007:3. no: CD005494.
3. France R. A review of fetal circulation and the segmental approach to fetal echocardiography. J Diagn Med Sonogr. 2006;22(1):29-31.
4. Blackburn S. Placental, fetal and transitional circulation revisited. J Perinat Neonatal Nurs 2006;20:290-294.
5. Cornfield D, Maynard R, deRegnier R, Guiang S, Barbato J, Milla C. Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near term infants with respiratory failure and pulmonary hypertension. Pediatrics. 1999;104:1089-1094.
6. Macrae D. Drug therapy in persistent pulmonary hypertension of the newborn. Semin Fetal Neonatal Med. 1997;2:49-58.
7. Gupta A, Rastogi S, Sahni R, et al. Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn-a single-center, 5-year experience. J Perinatol. 2002;22:435-441.
8. Leibovitch L, Matok I, Paret G, Therapeutic applications of sildenafil citrate in management of paediatric pulmonary hypertension. Drugs. 2007;67(1):57-73.
9. Boden G, Bennett C. The management of persistent pulmonary hypertension of the newborn. Curr Pediatr. 2004;14:290-297.
10. Filan P, McDougall P, Shekerdemian L. Combination pharmacotherapy for severe neonatal pulmonary hypertension. J Paediatr Child Health. 2006;42:219-220.
11. Weinberger B, Weiss K, Heck D, Laskin D, Laskin J. Pharmacologic therapy of persistent pulmonary hypertension of the newborn. Pharmacol Ther. 2001;89:67-79.
12. Namachivayam P, Theilen U, Butt W, Cooper S, Penny D, Shekerdemian L. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med. 2006;174:1042-1047.
13. Davidson D, Barefield E, Kattwinkel J, et al. Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn. Pediatrics. 1999;104:231-236.
14. Sastry B, Narasimham C, Reddy N, Raju B. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol. 2004;43:1149-1153.
15. Galie N, Ghofrani H, Torbicki Barst R, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353(20):2148-2157. (Pubitemid 41653106)
16. Leuchte H, Schwaiblmair M, Baumgartner R, Neurohr C, Kolbe T, Behr J. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension. J Am Coll Chest Physicians. 2004;125:580-586.
17. Young T, Mangum B. Neofax: A Manual of Drugs Used in Neonatal Care. 22nd ed. Montvale, NJ: Thomson Healthcare; 2009.